IntegraGen Balance Sheet Health
Financial Health criteria checks 3/6
IntegraGen has a total shareholder equity of €2.0M and total debt of €1.1M, which brings its debt-to-equity ratio to 55.9%. Its total assets and total liabilities are €8.0M and €6.0M respectively. IntegraGen's EBIT is €32.9K making its interest coverage ratio -0.6. It has cash and short-term investments of €2.9M.
Key information
55.9%
Debt to equity ratio
€1.12m
Debt
| Interest coverage ratio | -0.6x |
| Cash | €2.88m |
| Equity | €2.01m |
| Total liabilities | €5.99m |
| Total assets | €8.00m |
Recent financial health updates
No updates
Financial Position Analysis
Short Term Liabilities: ALINT's short term assets (€7.7M) exceed its short term liabilities (€5.2M).
Long Term Liabilities: ALINT's short term assets (€7.7M) exceed its long term liabilities (€808.6K).
Debt to Equity History and Analysis
Debt Level: ALINT has more cash than its total debt.
Reducing Debt: ALINT's debt to equity ratio has increased from 20.7% to 55.9% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: Insufficient data to determine if ALINT has enough cash runway based on its current free cash flow.
Forecast Cash Runway: Insufficient data to determine if ALINT has enough cash runway if its free cash flow continues to grow or shrink based on historical rates.